Platelet and immune signature associated with a rapid response to the BNT162b2 mRNA COVID-19 vaccine.
Davide FlegoSimone CesaroniGiulio Francesco RomitiBernadette CoricaRamona MarrapodiNoemi ScafaFrancesca MaiorcaLudovica LombardiDavide PallucciFabio PulcinelliValeria RaparelliMarcella VisentiniRoberto CangemiSilvia PiconeseDomenico AlvaroAntonella PolimeniStefania BasiliLucia Stefanininull nullPublished in: Journal of thrombosis and haemostasis : JTH (2022)
We identified features of the platelet-immune crosstalk that are associated with the development of a rapid humoral response to an mRNA-based vaccine (BNT162b2) and that could be exploited as early biomarkers of vaccine efficacy.